Beihai Gofar Chuanshan Biological Co Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

9.81

EPS

—

Div Yield, %

—

Shrs. gr., 5y

2.45%

Rev. gr., 5y

6.27%

Revenues

340m

-7.77%

Net income

-94m

CFO

Dividend

Jul 09, 20030.1 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Beihai Gofar Chuanshan Biological Co., Ltd. engages in the production and distribution of pharmaceutical products in China. The company offers various medicines and medical devices; and produces and sells pearl eyesight eye drops, gastrointestinal granules, pearl powder, and other proprietary Chinese medicines. It also provides molecular medical imaging and tumor radiotherapy centers, as well as tumor telemedicine technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in May 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was founded in 1993 is based in Beihai, China.

URL

http://www.gofar.com.cn/

IPO date

Jan 14, 2003

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT